In the final quarter of 2025, the Harbor International Compounders Fund reported a return of 3.19%, falling short of its benchmark, the MSCI All Country World ex-US Index, which gained 5.05%. This period saw strategic adjustments to the fund's holdings, including significant purchases in emerging sectors and divestments from established positions. Looking ahead to 2026, the fund's managers foresee a potential recalibration in global markets, emphasizing the importance of fundamental value, broad diversification, and solid earnings performance beyond the U.S. financial landscape. This forward-looking perspective underpins the fund's strategic realignments, preparing it for an evolving investment climate.
Amidst a quarter where the Harbor International Compounders Fund posted a return below its benchmark, key stock selections such as AstraZeneca and SSE provided positive contributions. AstraZeneca benefited from strong momentum in oncology, while SSE's strategic clarity helped mitigate investor concerns regarding its financial health. Concurrently, the fund strategically broadened its portfolio by acquiring shares in Contemporary Amperex Technology, Mercado Libre, Rheinmetall, and Tesco. These additions reflect a deliberate move towards areas of anticipated growth and value. On the other hand, the fund systematically divested from holdings like Novo Nordisk, Atlas Copco, SMC, Ferguson, and Diageo, with the decision to exit Novo Nordisk specifically stemming from a diminishing confidence in its future pricing capabilities and increasing competitive pressures.
Quarterly Performance and Strategic Portfolio Adjustments
In the fourth quarter of 2025, the Harbor International Compounders Fund experienced a return of 3.19%, which was below the 5.05% gain recorded by its benchmark, the MSCI All Country World ex-US Index. Despite this underperformance, specific investments significantly boosted the fund's results. AstraZeneca's robust performance in oncology, driven by promising results, and SSE's reassuring strategic guidance on funding were notable positive contributors. These successes highlight the fund's ability to identify and capitalize on strong individual company performances even within a challenging market environment. The nuanced performance reflects a market influenced by various global economic factors.
During the same period, the fund executed several key portfolio adjustments to optimize its positioning. New acquisitions included Contemporary Amperex Technology, signaling an investment in innovative energy solutions; Mercado Libre, targeting growth in Latin American e-commerce; Rheinmetall, a strategic play in the industrial sector; and Tesco, reflecting a re-evaluation of opportunities in consumer retail. Furthermore, the fund augmented its stake in Prosus, reinforcing its conviction in that company's long-term prospects. Conversely, the fund liquidated its positions in Novo Nordisk, Atlas Copco, SMC, Ferguson, and Diageo. The decision to sell Novo Nordisk was particularly strategic, driven by concerns about its weakening pricing power and a more competitive landscape. These shifts underscore a proactive management approach, adapting the portfolio to evolving market dynamics and fundamental assessments of company value.
2026 Market Outlook and Investment Philosophy
As the Harbor International Compounders Fund looks ahead to 2026, its management anticipates a significant shift in market dynamics. The prevailing sentiment is that forces will converge to drive a reorientation towards fundamental analysis, emphasizing diversification and a greater appreciation for earnings quality outside of the United States. This outlook suggests a potential move away from speculative growth and towards more tangible value, presenting both challenges and opportunities for investors. The fund is keenly focused on preparing its portfolio for an environment where robust company financials and judicious asset allocation are expected to be paramount. This proactive stance aims to leverage anticipated market shifts for sustained long-term growth.
The investment philosophy for 2026 is grounded in a belief that a broader market engagement is imminent. With the U.S. equity market comprising approximately 65% of global equity indexes, historical precedents suggest caution and a need for greater international diversification. The fund plans to achieve this by prioritizing high-quality companies with strong earnings potential, expanding global diversification, and strategically investing in structural growth themes. These themes include the burgeoning markets of China and India, alongside the rapidly evolving artificial intelligence infrastructure sector. This strategy is designed to mitigate concentration risks associated with a heavily U.S.-centric market and to capture growth from diverse global economies, ensuring the portfolio is resilient and capable of performing across various economic scenarios.
